Results 111 to 120 of about 108,448 (307)
Clinical Advances in Periodontics, Volume 12, Issue 4, Page 224-232, December 2022., 2022 Abstract Background With technological advancements in reconstructive periodontology, traditional protocols for the treatment of gingival recessions (GRs) can be challenged. This manuscript presents preliminary findings of a novel minimally‐invasive approach for the regenerative treatment of multiple adjacent GR defects. Methods Two healthy adults were
Shayan Barootchi +2 more
wiley +1 more source
Food allergy: Response to treatment with sodium cromoglycate [PDF]
, 1979 J. B. G. Watson, James Timmins
openalex +1 more source
The Indirect Costs of Avoidance in Food Allergy Management: A Scoping Review
AllergiesBackground: Food allergy management requires avoidance of allergenic food. While the direct costs of food allergy management have been described, avoidance may also contribute to time and opportunity costs.
Jennifer L. P. Protudjer +1 more
doaj +1 more source
The Role of Personality in Daily Food Allergy Experiences
Frontiers in Psychology, 2018 Food allergies present numerous challenges to coping in everyday life. Even simple things like planning a lunch with a friend can be stressful for people with food allergies. But are some people more adversely impacted by having a food allergy than other
Tamlin S. Conner +3 more
doaj +1 more source
Food-bridging: a new network construction to unveil the principles of cooking [PDF]
arXiv, 2017 In this manuscript we propose, analyse, and discuss a possible new principle behind traditional cuisine: the Food-bridging hypothesis and its comparison with the food-pairing hypothesis using the same dataset and graphical models employed in the food-pairing study by Ahn et al. [Scientific Reports, 1:196 (2011)].
arxiv
TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management
American Journal of Hematology, EarlyView.ABSTRACT Alterations in the tumor suppressor gene TP53 are common in human cancers and are associated with an aggressive nature. Approximately 8%–12% of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) harbor TP53 mutations (TP53mut) and present immense challenges due to inherent chemoresistance and poor outcomes.
Mithun Vinod Shah +2 more
wiley +1 more source
Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives
American Journal of Hematology, EarlyView.ABSTRACT Myelofibrosis (MF) is a myeloproliferative neoplasm that is accompanied by driver JAK2, CALR, or MPL mutations in more than 90% of cases, leading to constitutive activation of the JAK–STAT pathway. MF is a multifaceted disease characterized by trilineage myeloid proliferation with prominent megakaryocyte atypia and bone marrow fibrosis, as ...
Giuseppe G. Loscocco, Paola Guglielmelli
wiley +1 more source
Food Allergy: Facts and Fiction [PDF]
, 1989 Richard A. Schreiber, W. Allan Walker
openalex +1 more source
American Journal of Hematology, EarlyView.ABSTRACT In the Phase 3 DREAMM‐7 study of patients with relapsed/refractory multiple myeloma (RRMM) who received ≥ 1 prior therapy, belantamab mafodotin plus bortezomib and dexamethasone (BVd) demonstrated a progression‐free survival (PFS) benefit versus daratumumab plus bortezomib and dexamethasone (DVd).
Joshua Richter +13 more
wiley +1 more source